| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 668.9 | 939.0 | 761.3 | 782.3 | 750.9 |
| Age-adjusted comparative prevalence of diabetes, % | - | 9.4 | 7.6 | 7.8 | 8.0 |
| People with undiagnosed diabetes, in 1,000s | - | - | 284.0 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 37.3 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 557.0 | 1,086.3 | 1,111.1 | 1,037.9 |
| Age-adjusted comparative prevalence of IGT, % | - | 6.0 | 10.8 | 11.4 | 11.7 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 1,199.1 | 1,225.6 | 1,157.9 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 9.9 | 10.3 | 10.5 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 7,983.0 | 10,714.0 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 1.7 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 0.1 | - | - | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 0.1 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 0.4 | - | 0.3 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 0.5 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | 25,063.7 | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 24.6 | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 2,179.2 | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 2,912.8 | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 2,373.3 | 2,268.1 | 2,226.6 |
| Total diabetes-related health expenditure, ID million | - | - | 6,058.1 | 5,789.7 | 5,683.7 |
| Diabetes-related health expenditure per person, USD | - | 811.0 | 3,117.4 | 2,979.3 | 2,924.7 |
| Diabetes-related health expenditure per person, ID | - | - | 7,957.6 | 7,605.0 | 7,465.8 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 7,821.0 | 8,264.8 | 8,459.2 | 8,348.6 | 7,628.6 |
| Population of children (0-14 y), in 1,000s | 2,596.0 | - | 1,780.4 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 2,410.3 | - | - |